- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11. | Simris Group AB receives observation status | 75 | GlobeNewswire | Today, November 12, 2025, Simris Group AB (the "Company") disclosed its interim report for the third quarter of 2025 with information on the Company's financial situation.
The rules of Nasdaq... ► Artikel lesen | |
| 12.11. | Simris Group AB: Simris Group Interim Report January-september 2025 | 71 | GlobeNewswire (Europe) | QUARTER 3, JULY - SEPTEMBER 2025Net revenue decreased by 37% to SEK 484k (766k).EBITDA declined by 22% to SEK -3 639k (-2 971k).EBIT/Operating result declined by 8% to SEK -7 152k (-6 614k).INTERIM... ► Artikel lesen | |
| 10.11. | Simris Group AB: Simris Group announces leadership transition - Daniel Kubitza appointed interim CEO | 102 | GlobeNewswire (Europe) | The Board of Directors of Simris Group has appointed Daniel Kubitza as interim CEO, effective immediately.
Daniel Kubitza has over 20 years of experience in corporate financing, commercialization and... ► Artikel lesen | |
| 05.11. | Simris Group AB: Simris Group AB Announces Positive Results from Ongoing Antibody-Drug Conjugate (ADC) Study with Nuvisan | 99 | GlobeNewswire (Europe) | Simris Group AB's wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development... ► Artikel lesen | |
| 06.10. | Simris Group AB: Update Regarding In-Vitro Evaluation of Novel Advance Microcystin Payloads | 164 | GlobeNewswire (Europe) | Simris Group AB wholly owned subsidiary, Simris Biologics GmbH, today announced short technical delays in a previously announced study contracted with Nuvisan, a leading European contract research and... ► Artikel lesen | |
| 12.09. | Simris Group AB: Simris Biologics awarded €200K in non-dilutive funding for R&D programme to further develop microcystin payloads for Antibody Drug Conjugates (ADCs) | 797 | GlobeNewswire (Europe) | Simris Group AB, a pioneer in the development of novel, next-generation Antibody Drug Conjugate (ADC) payloads based on Microcystin (MC) toxin variants, announces that funding has been approved for... ► Artikel lesen | |
| 13.08. | Simris Group AB: Simris Group Interim Report January-june 2025 | 154 | GlobeNewswire (Europe) | QUARTER 2, APRIL - JUNE 2025Net revenue increased by 8% to SEK 687k (634k).EBITDA improved by 51% to SEK -2 980k (-6 117k).EBIT/Operating result improved by 32% to SEK -6 693k (-9 822k).INTERIM PERIOD... ► Artikel lesen | |
| SIMRIS GROUP Aktie jetzt für 0€ handeln | |||||
| 14.07. | Simris Group AB: Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review | 141 | GlobeNewswire (Europe) | Simris Group AB (publ), through its subsidiary Simris Biologics GmbH, announces that the EU-based biopharmaceutical company with which it had signed a non-binding concept sheet for a potential antibody-drug... ► Artikel lesen | |
| 28.05. | Simris Group AB: Bulletin from Simris Group AB's annual general meeting | 267 | GlobeNewswire (Europe) | Simris Group AB (publ), reg. no. 556841-9187 (the "Company"), held its annual general meeting on 28 May 2025. Below follows a summary of the resolutions that were passed at the general meeting.
Income... ► Artikel lesen | |
| 14.05. | Simris Group AB: Simris Group Interim Report January-march 2025 | 317 | GlobeNewswire (Europe) | QUARTER 1, JANUARY - MARCH 2025Net revenue decreased by 69 percent to SEK 159k (519k).EBITDA improved by 30 percent to SEK -3 724k (-5 325k). EBIT/ operating result improved by 19 percent to SEK -7... ► Artikel lesen | |
| 26.02. | Simris Group AB: Simris Group Year-end Report January-december 2024 | 195 | GlobeNewswire (Europe) | QUARTER 4, OCTOBER - DECEMBER 2024Net revenue decreased by 63 percent to SEK 971k (2 657k).EBITDA improved by 41 percent to SEK -3 180k (-5 403k).EBIT/Operating result deteriorate by 6 percent to SEK... ► Artikel lesen | |
| 04.02. | The observation status for Simris Group AB is removed | 307 | GlobeNewswire | On October 24, 2024, the shares in Simris Group AB (the "Company") were given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND MEAT | 0,765 | +1,14 % | 1 Reason to Think Twice Before Buying Beyond Meat (BYND) Stock This Week -- or Any Week | ||
| OATLY GROUP | 10,050 | -0,50 % | DA Davidson senkt Kursziel für Oatly auf 14 US-Dollar, behält aber Kaufempfehlung bei | ||
| CONAGRA BRANDS | 15,500 | +0,54 % | Passives Einkommen: Conagra: Stabiler Cashflow und beeindruckende 8 % Rendite | © Foto: DALL-EDie Aktie von Conagra Brands ist tief gefallen - doch ihre hohe Dividendenrendite weckt neues Interesse. Dank starker Marken und solider Bilanzen ist der Konsumriese ein zuverlässiger... ► Artikel lesen | |
| AGRARIUS | - | - | Agrarius AG: "Konzernjahresfehlbetrag sinkt von 2,37 auf 1,98 Mio. Euro - 221 Hektar Ackerland im Eigentum" - HV-Bericht von GSC-Research | - im Anhang finden Sie den HV-Bericht von GSC-Research.Anhang: HVAGRARIUS2025.pdfDen vollständigen Artikel lesen ... ► Artikel lesen | |
| WINGSTOP | 206,00 | -3,74 % | Dividendenbekanntmachungen (21.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,065 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,27 USD 0,2341 EUR ALPHAMIN... ► Artikel lesen | |
| WH GROUP | 0,910 | -2,67 % | Dividendenbekanntmachungen (06.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) COMPANHIA ENERGETICA DE MINAS GERAIS-CEM ... US2044096012 0,0397 USD 0,0338 EUR COMPANHIA ENERGETICA DE MINAS GERAIS-CEM ... US2044098828 0... ► Artikel lesen | |
| ELSE NUTRITION | 0,120 | +12,57 % | Else Nutrition Holdings Inc.: Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based ... | New Federal Budget Agreement Ends Government Shutdown and Expedites FDA Pathway for Innovative, Non-Soy, Plant-Based Infant Nutrition Under Operation Stork Speed... ► Artikel lesen | |
| MHP | 4,500 | -0,44 % | MHP has successfully closed the transaction to acquire over 92% stake in Grupo UVESA | KYIV, Ukraine, Aug. 4, 2025 /PRNewswire/ -- MHP, a leading international food and agri company, has officially closed the transaction to acquire over 92% of the share capital of Grupo UVESA... ► Artikel lesen | |
| BIOGAIA | 9,150 | -1,08 % | BioGaia AB and University of Gothenburg discovered a new role for bacteria present in the gut: serotonin production | Often considered as our "second brain", the human gut and its resident microbiota play a crucial bidirectional role communicating the brain (central nervous system) with the gut (enteric nervous system)... ► Artikel lesen | |
| JACK IN THE BOX | 13,300 | -8,90 % | Jack in the Box vor Umbaujahr 2026: UBS bestätigt "Neutral"-Rating | ||
| J&J SNACK FOODS | 78,00 | +1,30 % | J&J Snack Foods declares $0.80 dividend | ||
| CAVA GROUP | 48,910 | +12,27 % | CAVA Group (CAVA) Climbs 12%, Mirrors Market Rally on Rate Cut Hopes | ||
| MCDONALDS | 268,40 | -0,06 % | McDonald's Hassliebe, Zahlen & Zukunft! Aktien Analyse | McDonald's Hassliebe, Zahlen & Zukunft! Aktien Analys ► Artikel lesen | |
| KRAFT HEINZ | 21,960 | +0,07 % | Is Kraft Heinz's 6.4%-Yielding Dividend Safe? | ||
| FIRST WATCH RESTAURANT GROUP | 16,570 | +8,87 % | First Watch auf der Stephens Conference: Strategische Preisgestaltung im Inflationsumfeld |
Das Unternehmen SIMRIS GROUP AB kann der Branche Nahrungsmittel/Agrar zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,004 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SIMRIS GROUP AB finden Sie auf Wallstreet Online.